In conclusion, the current study provided evidence that the PB levels of PDL-1, CTLA-4, PD-1, FOXP3, MIC-B, miR-155, and miR-195 could be used as promising diagnostic markers for BC patients. This evidence concerns the gene MICB and breast cancer.